Biotricity Statistics
Total Valuation
Biotricity has a market cap or net worth of 7.18 million. The enterprise value is 33.37 million.
| Market Cap | 7.18M |
| Enterprise Value | 33.37M |
Important Dates
The next estimated earnings date is Thursday, February 13, 2025.
| Earnings Date | Feb 13, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
Biotricity has 24.56 million shares outstanding. The number of shares has increased by 57.64% in one year.
| Current Share Class | n/a |
| Shares Outstanding | 24.56M |
| Shares Change (YoY) | +57.64% |
| Shares Change (QoQ) | +58.75% |
| Owned by Insiders (%) | 49.92% |
| Owned by Institutions (%) | 0.23% |
| Float | 9.22M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 0.32 |
| PB Ratio | n/a |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -2.08 |
| EV / Sales | 2.64 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.19
| Current Ratio | 0.19 |
| Quick Ratio | 0.10 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -1.02 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | -59.33% |
| Return on Capital (ROIC) | n/a |
| Revenue Per Employee | 229,452 |
| Profits Per Employee | -291,771 |
| Employee Count | 55 |
| Asset Turnover | 2.08 |
| Inventory Turnover | 1.70 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -68.64% in the last 52 weeks. The beta is 1.33, so Biotricity's price volatility has been higher than the market average.
| Beta (5Y) | 1.33 |
| 52-Week Price Change | -68.64% |
| 50-Day Moving Average | 0.33 |
| 200-Day Moving Average | 0.74 |
| Relative Strength Index (RSI) | 47.36 |
| Average Volume (20 Days) | 53,325 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | 1.96 |
Income Statement
In the last 12 months, Biotricity had revenue of 12.62 million and -16.05 million in losses. Loss per share was -1.16.
| Revenue | 12.62M |
| Gross Profit | 9.26M |
| Operating Income | -5.75M |
| Pretax Income | -12.25M |
| Net Income | -16.05M |
| EBITDA | -5.74M |
| EBIT | -5.75M |
| Loss Per Share | -1.16 |
Balance Sheet
The company has 746,944 in cash and 23.01 million in debt, giving a net cash position of -22.26 million or -0.91 per share.
| Cash & Cash Equivalents | 746,944 |
| Total Debt | 23.01M |
| Net Cash | -22.26M |
| Net Cash Per Share | -0.91 |
| Equity (Book Value) | -27.23M |
| Book Value Per Share | -1.35 |
| Working Capital | -17.42M |
Cash Flow
| Operating Cash Flow | -4.36M |
| Capital Expenditures | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Margins
Gross margin is 73.40%, with operating and profit margins of -45.57% and -97.04%.
| Gross Margin | 73.40% |
| Operating Margin | -45.57% |
| Pretax Margin | -97.04% |
| Profit Margin | -97.04% |
| EBITDA Margin | -45.52% |
| EBIT Margin | -45.57% |
| FCF Margin | n/a |
Dividends & Yields
Biotricity does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -57.64% |
| Shareholder Yield | -57.64% |
| Earnings Yield | -398.22% |
| FCF Yield | n/a |
Stock Splits
The last stock split was on July 3, 2023. It was a reverse split with a ratio of 0.1666667.
| Last Split Date | Jul 3, 2023 |
| Split Type | Reverse |
| Split Ratio | 0.1666667 |
Scores
Biotricity has an Altman Z-Score of -40.94. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -40.94 |
| Piotroski F-Score | n/a |